Sun Pharma gets USFDA nod for generic cardiac tablets

01 Aug 2011 Evaluate

Sun Pharmaceutical Industries had received tentative approval from the US health regulator for its generic clopidogrel tablets used for treating heart ailments. United States Food and Drug Administration (USFDA) have granted the company's subsidiary a tentative approval for its abbreviated new drug application (ANDA) for generic clopidogrel tablets USP.

The generic clopidogrel tablets USP in the strength of 75 mg are equivalents of Sanofi Aventis's Plavix tablets. Clopidogrel tablets USP have annual sale of about $6 billion in America. The tablets are indicated for the treatment of acute coronary syndrome, recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease.crackcrack

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×